Vir Biotechnology Inc. share price logo

Vir Biotechnology Inc.

NASDAQ: VIR

Small Cap

$8.96

+0.07

(+0.84%)

Live

as on

Vir Biotechnology Inc. Stock Performance

as on August 12, 2026 at 4:11 am IST

  • Day's Low

    Day's High

    $8.77
    $9.01
    downward going graph

    2.12%

    Downside

    0.56%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.16
    $11.66
    downward going graph

    53.63%

    Downside

    30.13%

    Upside

    downward going graph

Vir Biotechnology Inc. share price movements today

Previous Close
$8.89
Open
$9.01
Volume
343.6K
Day's Low - High
$8.77 - $9.01
52 Week Low - High
$4.16 - $11.66

Vir Biotechnology Inc. Historical Returns

1 Month Return
-10.74 %
3 Month Return
-4.31 %
1 Year Return
+ 107.71 %
3 Year Return
-33.51 %
5 Year Return
-77.29 %

Vir Biotechnology Inc. Stock Fundamentals & Key Indicators

Check Vir Biotechnology Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-1.8115

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.58%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-268.2M

Revenue (TTM)

303.2M

Profit Margin

-83.00%

Return On Equity TTM

-26.08%

Vir Biotechnology Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vir Biotechnology Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.5B-77.29%NA-83.00%NA
BUY$44.0B669.41%NA0.00%NA
BUY$125.7B168.33%28.9135.00%NA
BUY$80.8B32.8%19.4227.87%0.47000000000000003%

Stock Returns calculator for Vir Biotechnology Inc. Stock including INR - Dollar returns

The Vir Biotechnology Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vir Biotechnology Inc. investment value today

Current value as on today

₹2,27,914

Returns

₹1,27,914

(+127.91%)

Returns from Vir Biotechnology Inc. Stock

₹1,09,346 (+109.35%)

Dollar Impact

₹18,568 (+18.57%)

Analyst Recommendation on Vir Biotechnology Inc. Stock

Based on 13 analysts

BUY

69.23%

Buy

30.77%

Hold

0.00%

Sell

Based on 13 analysts, 69.23% of analysts recommend a 'BUY' rating for Vir Biotechnology Inc.. Average target price of $21.11

Vir Biotechnology Inc. Share Price Target

Get share price movements and forecasts by analysts on Vir Biotechnology Inc..

What analysts predicted

57.56%UPSIDE

Target Price

$21.11

Current Price

$8.96

Analyzed by

13 Analysts

Target

$21.11

Vir Biotechnology Inc. target price $21.11, a slight upside of 57.56% compared to current price of $8.96. According to 13 analysts rating.

Indian Investors' Interest in Vir Biotechnology Inc. Stock

Search interest for Vir Biotechnology Inc. Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Vir Biotechnology Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
56
3
2
12
3
1
0
64
0
238
Gross Profit
-42
-102
-192
-76
-114
-96
-151
430
-2
238
Operating Income
-80
-158
-231
-117
-139
-118
-173
-36
-133
73
EBITDA
-73
-128
-215
-100
-135
-115
-159
-40
-122
78
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
4
4
2
2
2
2
2
2
2
2
Income Before Tax
-65
-139
-213
-104
-120
-110
-162
-43
-125
80
Income Tax Expense
0
-1
0
0
0
0
0
0
0
0
Net Income
-65
-138
-213
-104
-120
-110
-163
-42
-125
80
Net Profit Margin
-115.79%
-4500.10%
-8979.71%
-845.23%
-3989.61%
-9139.87%
-67975.42%
-66.99%
433431.03%
33.51%

Vir Biotechnology Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
76
1,095
1,615
86
74
68
Gross Profit
-62
-99
0
76
581
994
-486
-404
56
Operating Income
-81
-118
-177
-296
420
833
-684
-587
-468
EBITDA
-81
-115
-173
514
555
761
-641
-508
-426
Interest Expense
-
-
7
3
272
183
-
-
-
Depreciation
0
2
4
5
5
6
16
14
11
Income Before Tax
-80
-116
-174
-298
549
754
-628
-523
-437
Income Tax Expense
-10
0
0
0
21
238
-13
-1
0
Net Income
-69
-115
-174
-298
528
515
-615
-521
-437
Net Profit Margin
-46880.54%
-13350.69%
-24568.64%
-391.09%
48.25%
31.92%
-713.69%
-703.40%
-638.87%

Vir Biotechnology Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-138
-213
-104
-120
-110
-163
-42
-125
-45
Operating Cash Flow
-77
-171
-87
-78
-120
-167
-25
-132
-9
Investing Cash Flow
211
118
140
126
56
40
86
11
-185
Financing Cash Flow
2
0
1
0
2
0
1
162
240
Change in Cash
136
-52
54
49
-61
-127
61
41
46

Vir Biotechnology Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-115
-174
-298
528
515
-615
-521
-437
Operating Cash Flow
-94
-129
-190
-47
1,663
-778
-446
-391
Investing Cash Flow
-60
-256
-9
-140
-1,193
164
499
310
Financing Cash Flow
24
449
529
100
34
7
4
3
Change in Cash
-129
63
328
-88
504
-606
57
-77

Global Institutional Holdings in Vir Biotechnology Inc.

Funds
Holdings
Morgan Stanley - Brokerage Accounts
1.69%
Balyasny Asset Management LLC
0.81%
Soleus Capital Management, L.P.
1.18%
Bank of America Corp
0.55%
Millennium Management LLC
0.59%

Insights on Vir Biotechnology Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -29.0K → 238.94M (in $), with an average increase of 100.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, VIR stock has moved up by 107.7%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -125.69M → 80.07M (in $), with an average increase of 257.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 496.5% return, outperforming this stock by 388.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 590.1% return, outperforming this stock by 623.6%

About Vir Biotechnology Inc.

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
OrganisationVir Biotechnology Inc.
Headquarters1800 Owens Street, San Francisco, CA, United States, 94158
IndustryBiotechnology
CEODr. Marianne De Backer M.B.A., M.Sc., Ph.D.
E-voting on sharesClick here to vote

Key Management of Vir Biotechnology Inc.

Name

Title

Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.

President, CEO & Director

FAQs

What is Vir Biotechnology Inc. share price today?

Vir Biotechnology Inc. share price today is $8.96 as on . Vir Biotechnology Inc. share today touched a day high of $9.01 and a low of $8.77.

What is the 52 week high and 52 week low for Vir Biotechnology Inc. share?

Vir Biotechnology Inc. share touched a 52 week high of $11.66 on and a 52 week low of $4.16 on . Vir Biotechnology Inc. stock price today i.e. is trending at $8.96,which is 23.16% down from its 52 week high and 115.64% up from its 52 week low.

What is Vir Biotechnology Inc.'s market capitalisation today?

Vir Biotechnology Inc. market capitalisation is $0.00T as on .

How to invest in Vir Biotechnology Inc. Stock (VIR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vir Biotechnology Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vir Biotechnology Inc. Shares that will get you 0.1674 shares as per Vir Biotechnology Inc. share price of $8.96 per share as on August 11, 2026 at 10:41 pm IST.

What is the minimum amount required to buy Vir Biotechnology Inc. Stock (VIR) from India?

Indian investors can start investing in Vir Biotechnology Inc. (VIR) shares with as little as ₹95.435 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.35 in Vir Biotechnology Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Vir Biotechnology Inc. share’s latest price of $8.96 as on August 11, 2026 at 10:41 pm IST, you will get 1.1161 shares of Vir Biotechnology Inc.. Learn more about fractional shares .

What are the returns that Vir Biotechnology Inc. has given to Indian investors in the last 5 years?

Vir Biotechnology Inc. stock has given -77.29% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?